Mariner
GMED icon

Mariner’s Globus Medical GMED Stock Holding History

Mariner’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-62,932
Closed -$5.42M – 3686
2026
Q1 		$5.42M Buy
62,932
+55,843
+788% +$5.01M 0.01% 1026
2025
Q4 		$621K Sell
7,089
-3,931
-36% -$298K ﹤0.01% 2299
2025
Q3 		$631K Sell
11,020
-8,964
-45% -$516K ﹤0.01% 2248
2025
Q2 		$1.18M Sell
19,984
-1,056
-5% -$68.2K ﹤0.01% 1685
2025
Q1 		$1.54M Buy
21,040
+7,256
+53% +$600K ﹤0.01% 1385
2024
Q4 		$1.14M Buy
13,784
+1,342
+11% +$106K ﹤0.01% 1557
2024
Q3 		$890K Sell
12,442
-5,211
-30% -$368K ﹤0.01% 1704
2024
Q2 		$1.21M Buy
17,653
+29
+0.2% +$1.73K ﹤0.01% 1386
2024
Q1 		$945K Sell
17,624
-533
-3% -$28.7K ﹤0.01% 1543
2023
Q4 		$968K Sell
18,157
-49,378
-73% -$2.41M ﹤0.01% 1450
2023
Q3 		$3.35M Buy
67,535
+25,572
+61% +$1.43M 0.01% 778
2023
Q2 		$2.5M Buy
41,963
+16,718
+66% +$953K 0.01% 888
2023
Q1 		$1.43M Buy
25,245
+5,468
+28% +$351K ﹤0.01% 1106
2022
Q4 		$1.47M Buy
19,777
+3,071
+18% +$209K ﹤0.01% 1056
2022
Q3 		$995K Buy
16,706
+1,277
+8% +$76.9K ﹤0.01% 1048
2022
Q2 		$866K Buy
15,429
+318
+2% +$20.9K ﹤0.01% 953
2022
Q1 		$1.11M Buy
15,111
+4,569
+43% +$318K ﹤0.01% 901
2021
Q4 		$761K Buy
+10,542
New +$765K ﹤0.01% 906
2020
Q4 		– Sell
-20,886
Closed -$1.03M – 791
2020
Q3 		$1.03M Sell
20,886
-648
-3% -$33.4K 0.01% 498
2020
Q2 		$1.03M Buy
21,534
+3,543
+20% +$171K 0.01% 482
2020
Q1 		$765K Buy
+17,991
New +$889K 0.01% 516
2019
Q3 		– Sell
-83,345
Closed -$3.52M – 820
2019
Q2 		$3.52M Buy
+83,345
New +$3.62M 0.04% 301

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Mariner's GMED Position: Q2 2026 in Review

Mariner sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 62,932 shares — an estimated $5.42M sold.

Mariner first reported a position in GMED in Q2 2019 and held it in 22 quarters. The position peaked at $5.42M in Q1 2026. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Mariner reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
  • Mariner sold 62,932 Globus Medical shares in Q2 2026, an estimated $5.42M.
  • Mariner first reported a position in Globus Medical in Q2 2019 and held it in 22 quarters.
  • Mariner's Globus Medical position peaked at $5.42M in Q1 2026.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.